Accelerated Cross-Linking in Children: New Australian Results Across the Tasman
Keratoconus often behaves more aggressively in children than in adults, so paediatric cross-linking gets a lot of attention. A new study from Queensland Children's Hospital in Brisbane reports how children responded to an accelerated form of cross-linking, and, for the first time, looks at outcomes in Aboriginal and Torres Strait Islander children. We read the full text, and here is what it shows, and what it does not.
If you want the longer-term picture of cross-linking in children compared with adults, we covered that in our earlier post on five-year cross-linking results in children, teenagers and adults. This article focuses on what is new.
How the study was done
This was a single-centre, retrospective cohort study, meaning the team reviewed hospital records of every child (18 or younger) who had accelerated cross-linking for keratoconus between November 2018 and June 2023 and had at least six months of follow-up. Children were treated if scans or vision showed progression over six to twelve months, for example the steepest point of the cornea (Kmax) increasing by at least 1 dioptre.
The treatment was epithelium-off accelerated cross-linking under general anaesthetic: riboflavin (vitamin B2) drops every two minutes for 20 minutes, then ultraviolet light at 9 mW/cm² for 10 minutes, instead of the 30 minutes used in the standard "Dresden" protocol. Outcomes were measured with a Pentacam scanner and a letter chart at six and twelve months.
The study included 59 eyes of 43 children, with a median age of 14 (range 9 to 17). Many had advanced disease: 72.9% of eyes were classed as advanced or severe, with an average Kmax of 61.2 dioptres. There was no untreated or standard cross-linking comparison group.
What they found
At six months: signs of stability
Kmax flattened by an average of 2.09 dioptres (95% confidence interval 0.23 to 3.95; P = 0.029). Corneal thickness at the thinnest point reduced by 18.27 µm (95% CI 4.35 to 32.19; P = 0.012). Vision with glasses (P = 0.613) and astigmatism (P = 0.751) did not change significantly.
A quick guide to those numbers: the confidence interval is the range in which the true average change most plausibly sits, and the P-value estimates how likely a result this large would be if there were really no change. A P-value below 0.05 is conventionally taken as "unlikely to be chance alone". Here the Kmax interval is wide (from barely any flattening to almost 4 dioptres), so the size of the effect is uncertain even though the direction is consistent. The effect was concentrated in the advanced-disease group, the only subgroup large enough to analyse.
Some thinning after cross-linking is a known finding and does not necessarily mean the keratoconus is getting worse; the authors suggest the stiffened cornea becomes more compact. This is a good reminder that thickness, curvature and vision need to be read together.
At twelve months: inconclusive
Only 20 to 23 eyes had usable twelve-month data, largely because COVID-19 restrictions turned appointments into phone calls. Among 20 eyes, 70% (14 of 20) did not meet the progression criterion, while 30% (6 of 20) had Kmax increase by 1 dioptre or more. No outcome changed significantly from baseline (Kmax P = 0.273). The authors are clear that the twelve-month results should be interpreted as inconclusive rather than evidence of no effect.
Aboriginal and Torres Strait Islander children
Aboriginal and Torres Strait Islander children made up 20.9% of patients (12 eyes of nine children), much higher than their share of the Australian population (reported at 3.3%). The study found no statistically significant association between Aboriginal and Torres Strait Islander status and any of the four outcomes at six or twelve months. With only nine children, this means no difference was detected, not that the groups have been shown to respond identically. The authors call for more research into causes, risk factors and long-term outcomes in these communities.
New Zealand has its own population and its own patterns of keratoconus. These findings should not be assumed to apply to Māori or Pacific children; local data are needed, which is part of the work supported by the New Zealand Eye Research Centre.
Side effects
Corneal haze was recorded in 22% of eyes, sterile inflammatory infiltrates in 5.1% and infectious keratitis in 3.4%. All settled on their own or with eye drops.
What the studies can't tell us
- Retrospective, single centre, no comparison group. We cannot say how these children would have done without treatment or with standard cross-linking.
- Large loss of data at twelve months. Fewer than half of the eyes had twelve-month results, so longer-term stability is uncertain.
- Short follow-up. Twelve months is short for a condition that can change throughout the teenage years.
- Possible selection bias. The authors note the high share of Aboriginal and Torres Strait Islander children may reflect referral patterns.
- Funding was not reported in the text we read; all five authors declared no conflicts of interest.
Although the authors describe cross-linking as halting progression, we would put it more cautiously: this study suggests early stabilisation in most eyes at six months, with less certainty after that.
What this means for your family
Cross-linking is performed by an ophthalmologist, but the decision depends on good evidence of progression, which starts with careful, repeated corneal mapping. A keratoconus-focused optometrist diagnoses keratoconus, tracks change between scans, refers at the right moment and keeps monitoring after treatment, since some eyes continue to change. Our post on repeat averaged corneal scans explains why this matters.
If your child has been diagnosed with keratoconus, or you are worried about eye rubbing or changing vision, the optometrists at Rose Optometry in Hamilton, including Jagrut Lallu and Jacqueline Rowe, can map the corneas, monitor progression and coordinate referral when needed. Learn more about keratoconus care at Rose Optometry or book a keratoconus assessment.
References
- Klejnotowska AE, et al. Visual and Topographic Outcomes of Accelerated Corneal Cross-Linking for Keratoconus in Indigenous and Non-Indigenous Children in Australia. Translational Vision Science & Technology. 2026. PMID 43006993. doi:10.1167/tvst.15.11.9



